Stockreport

NervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates [TheStreet.com]

NervGen Pharma Corp. - Common stock  (NGEN) 
PDF VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical com [Read more]